As Covid-19 has swept across the globe, the public has gotten a rare glimpse into the long, expensive process of drug development. But while health experts hope for a Covid-19 vaccine sometime in 2021, the reality is that most drugs travel a much longer and complex path to market, due largely to the time and expense of clinical trials
Read more here:
Despite recent challenges, venture capital firms are still seeking out investment opportunities across the country. Since our last analysis of most active VCs in January 2020, we've seen shake-ups across 10 states. Our graphic maps out the most active VC investor in every US state.
Read more here:
https://www.cbinsights.com/research/most-active-tech-venture-capital-firms-us-map/
EnsoData, a Madison, Wisconsin-based startup that is using artificial intelligence to analyze the human body to diagnose health conditions, today announced the close of $9 million in funding.
Read more here:
https://news.crunchbase.com/news/ensodata-raises-9m-to-diagnose-health-conditions-with-ai/
Laboratory Corporation of America Holdings LH or LabCorp recently announced a tie-up with Medable to expand its technology ecosystem. The expansion, undertaken by LabCorp’s drug development business Covance, is aimed at accelerating the adoption of decentralized clinical trials, which are often referred to as hybrid and virtual clinical trials.
Read more here:
Orbita, which provides conversational AI-powered voice and chatbot solutions for health care, today announced that it has raised $9 million. CEO Bill Rogers says the funding will be used to expand the company’s reach as it supports engagement and marketing in the life sciences market.
Read more here:
